IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome;Niveles de IGF-1 en diferentes estadios de esteatosis hepática y su relación con el síndrome metabólico

Acta Gastroenterologica Latinoamericana

Volumn 42, Issue 1, 2012, Pages 20-26

  Mallea Gil, María Susana ^a   Ballarino, María Carolina ^a   Spiraquis, Adriana ^a   Iriarte, Mariel ^a   Kura, Marta ^a   Gimenez, Silvia ^a   Oneto, Adriana ^b   Guitelman, Mirtha ^b   Machado, Rogelio ^a   Miguel, Carlos Mariano ^a  

^a HOSPITAL MILITAR CENTRAL   (Argentina)

^b Tomografia Computada Buenos Aires TCBA   (Argentina)

Author keywords

IGF 1; Liver steatosis; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C;

ADULT; ARTICLE; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84859477289     PISSN: 03009033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterolgy 1994;107:1103-1109.
2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43 (Suppl 1): S99-S112.
3. Schmid C. Insulin-like growth factors. Cell Biol Int 1995;19: 445-457.
4. Dunger D, Yuen K, Ong K. Insulin-like growth factor 1 and impaired glucose tolerance. Horm Res 2004;62 (Suppl 1):101-107.
5. Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care 2006;9:637-642.
6. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005;48:634-642.
7. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-1745.
8. Efstratiadis G, Tsiaousis G, Athyros VG; Karagianni D, Pavlitou-Tsionsti A, Giannakou-Darda A, Manes C. Total serum insulin-like growth factor-1 and C- reactive protein in metabolic syndrome with or without diabetes. Angiology 2006;57:303-311.
9. García- Galiano D, Sanchez-Garrido MA, Espejo I, Montero JL, Costán G, Marchal T, Membrives A, Gallardo-Valverde JM, Muñoz-Castañeda JR, Arévalo E, De la Mata M, Muntané J. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. Obesity Surgery 2007;17:493-503.
10. Ralls PW, Jhonson MB, Kanel G, Dobalian DM, Colletti PM, Boswell WD Jr, Radin DR, Halls JM. FM sonography in diffuse liver diseases prospective assesment and blinded analysis. Radiology 1986;161:451-454.
11. Marm CS, Bree RL, Silver TM. Ultrasonography of the liver: technique and focal and diffuse disease. Radiol Clin North Am 1991;29:1151-1170.
12. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
13. Balaban Y, Sumer H, Simsek H, Us D, Tatar G. Metabolic syndrome, nonalcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). Ann Hepatol 2006;5: 109-114.
14. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239.
15. Cusi K. Evolving concepts in lipotoxicity. The changing face of hepatology Postgraduate course 2008. American Association for the Study of Liver Diseases:72-84.
16. Cusi K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2009;16:141-149.
17. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab 2008;93:S74-S80.
18. Liangpunsakul S, Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the Third National Health and Nutrition Survey (NHANES III) Am J Med Sci 2005;329:111-116.
19. Hyegon Chang K, Sung Hee C, Hae Won S, Jae Youn C, Kwan Woo L, Hyun Chul L, Kap Bum H, Dae Jung K. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women. World J Gastroenterol 2005;11:5314-5321.
20. Parekh N, Roberts CB, Valdiveloo M, Puvananayagam T, Albu JB, Lu-Yao G. Lifestyle, anthropometric, and obesityrelated physiologic determinants of insulin-like growth factor- 1 in the Third National Health and Nutrition Examination Survey (1988-1994). Ann Epidemiol 2010;20:182-193.
21. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997;18:801-831.
22. Völke H, Nauck M, Rettig R, Dörr M, Higham C, Brabant G, Wallaschofski H. Association between hepatic steatosis and serum IGF-1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol 2009;161:705-713.
23. Clemmons D. Role of insulin-like growth factor 1 in maintaining normal glucose homeostasis. Horm Res 2004;62 (suppl 1):77-82.
24. Brugts MP, van Duijn CM, Hofland LJ, Witteman JC, Lamberts SW, Janssenl J IGF-1 bioactivity in an elderly population. Relation to insulin sensitivity, insulin levels, and the metabolic syndrome. Diabetes 2010;59:505-508.
25. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T. The severity metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102:2708-2715.